-
The Kindest Cut
Before undergoing surgery, cancer patients should look for experienced surgeons, get second opinions and ask about the risks and benefits.
by Stephen Ornes
-
Going Off-Label
Physicians are legally permitted to prescribe drugs approved for one purpose to be used for another, a practice called off-label prescribing. The rise of targeted therapies and immunotherapies is creating new challenges for navigating off-label options.
by Kate Yandell
-
Healthy Habits
Inflammation ConnectionCould a diet that leads to inflammation increase the risk of developing colorectal cancer?
by Lindsey Konkel
-
A Focus on Pediatric Cancer Screening
The AACR shares research papers that summarize recommendations for monitoring children and adolescents with cancer predisposition syndromes.
by Garrett M. Brodeur
-
Revised Prostate Cancer Screening Guidelines Proposed
The U.S. Preventive Services Task Force suggests an individualized approach to prostate cancer screening.
-
Immunotherapy Combinations
Researchers are combining immunotherapies with each other and with other treatments in hopes that a larger proportion of patients will have long-term benefits.
by Kate Yandell
-
Seeking a Second Opinion
Another perspective on your disease may help you find the best cancer care.
by Stephen Ornes
-
Healthy Habits
Tanning TroubleIndoor tanning is a major culprit in melanoma diagnosed early in life.
by Kate Yandell
-
Forward Look
Inside InflammationQ&A with molecular biologist Michael Karin on inflammation and cancer.
by Robin Meadows
Cancer Talk
Declining Breast Cancer Mortality in Younger Women
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin